Cargando…
Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation
Approximately 50% of patients with muscle-invasive bladder cancer (MIBC) develop metastatic disease, which is almost invariably lethal. However, our understanding of pathways that drive aggressive behavior of MIBC is incomplete. Members of the FOXA subfamily of transcription factors are implicated i...
Autores principales: | DeGraff, David J., Clark, Peter E., Cates, Justin M., Yamashita, Hironobu, Robinson, Victoria L., Yu, Xiuping, Smolkin, Mark E., Chang, Sam S., Cookson, Michael S., Herrick, Mary K., Shariat, Shahrokh F., Steinberg, Gary D., Frierson, Henry F., Wu, Xue-Ru, Theodorescu, Dan, Matusik, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349679/ https://www.ncbi.nlm.nih.gov/pubmed/22590586 http://dx.doi.org/10.1371/journal.pone.0036669 |
Ejemplares similares
-
Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS
por: Yee, Christopher H., et al.
Publicado: (2019) -
Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model
por: Yu, Xiuping, et al.
Publicado: (2010) -
Building bridges in urothelial carcinoma to face common challenges
por: Mathieu, Romain, et al.
Publicado: (2016) -
Contemporary concepts and controversies in the diagnosis and management of urothelial carcinoma
por: Shariat, Shahrokh F., et al.
Publicado: (2016) -
SOX2 expression in the developing, adult, as well as diseased prostate
por: Yu, Xiuping, et al.
Publicado: (2014)